logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12240850 B1

PDFFull Text
Date of Patent:
Mar. 04, 2025

Filed:

May. 09, 2023

Pharmaceutical compositions comprising 4-((6br, 10as)-3-methyl-2,3,6b,9,10, 10a-hexahydro-1h,7h-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-ol for treating central nervous system disorders

Applicant:

Intra-cellular Therapies, Inc., New York, NY (US);

Inventors:

Peng Li, New Milford, NJ (US);

Qiang Zhang, Plainsboro, NJ (US);

Robert Davis, San Diego, CA (US);

Lawrence P. Wennogle, Steamboat Springs, CO (US);

Assignee:

INTRA-CELLULAR THERAPIES, INC., Bedminster, NJ (US);

Attorney:

Hoxie & Associates LLC

Primary Examiner:

Douglas M Willis

Int. Cl.
CPC ...
A61K 31/437 (2006.01); A61K 9/48 (2006.01); A61K 9/50 (2006.01); A61K 31/4985 (2006.01); A61K 47/34 (2017.01); A61K 47/38 (2006.01); C07D 471/14 (2006.01); C07D 471/16 (2006.01); C07D 471/22 (2006.01);
U.S. Cl.
CPC ...
C07D 471/16 (2013.01); A61K 9/4825 (2013.01); A61K 9/4891 (2013.01); A61K 9/5031 (2013.01); A61K 31/4985 (2013.01); A61K 47/34 (2013.01); A61K 47/38 (2013.01); C07D 471/14 (2013.01);
Abstract

The invention relates to pharmaceutical compositions comprising compounds of Formula Q: wherein W is —N(CH)—, and Y is —CH(OH)—, in free base or pharmaceutically acceptable salt form, and methods of use in the treatment of diseases involving 5-HTreceptor, serotonin transporter (SERT) pathway and/or the dopamine Dreceptor pathway, and methods of treating conditions of the central nervous system therewith.

Find Patent Forward Citations

Li, Peng. (2025). Pharmaceutical compositions comprising 4-((6br, 10as)-3-methyl-2,3,6b,9,10, 10a-hexahydro-1h,7h-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-ol for treating central nervous system disorders (U.S. Patent No. 12240850). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12240850

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…